Esodel - 40 is a meticulously formulated pharmaceutical product featuring Esomeprazole as the active ingredient, delivered in a 40mg dosage form. The formulation is designed to ensure optimal dissolution, bioavailability, and shelf-life stability. The tablet is produced using advanced excipient combinations, including microcrystalline cellulose, magnesium stearate, and colloidal silicon dioxide, which enhance flow properties, tablet hardness, and disintegration rates. The manufacturing process incorporates direct compression techniques to maintain the integrity of Esomeprazole’s pharmacological activity, ensuring uniform content distribution across all tablets. The final product is coated with a gastro-resistant layer to protect the active ingredient from gastric acid, ensuring targeted release in the duodenum. The formulation adheres to stringent pharmaceutical standards, with a focus on chemical stability under varied storage conditions and compatibility with excipients to prevent degradation.
Manufacturing Capability
Delwis Healthcare’s manufacturing infrastructure is equipped to produce Esodel - 40 with precision and scalability. The facility features state-of-the-art tablet compression lines, coating systems, and packaging machinery, enabling consistent production of high-quality tablets. Sterile processing capabilities are maintained through Class 100/1000 cleanrooms, ensuring contamination-free environments for critical manufacturing steps. All processes comply with current Good Manufacturing Practices (cGMP), with rigorous validation protocols for equipment, processes, and materials. The facility supports large-scale production, with the capacity to meet bulk supply demands for global markets. Quality systems are integrated throughout the manufacturing lifecycle, including real-time monitoring of critical parameters such as tablet weight, hardness, and disintegration time. Additionally, the infrastructure is designed for seamless scalability, allowing adjustments to production volumes without compromising product quality or regulatory compliance.
Available Strengths and Packaging
Composition: Esomeprazole 40mg Tab
Packaging: 10x10 Alu Alu
Esodel - 40 is available in a single dosage strength of 40mg, tailored for pharmaceutical manufacturers requiring standardized formulations. The packaging consists of 10x10 aluminum blister packs, ensuring robust protection against moisture, light, and physical damage. This packaging format is ideal for bulk supply, offering convenience for storage, transportation, and retail distribution. The aluminum blister design also facilitates tamper-evident sealing, enhancing product security and compliance with regulatory requirements for pharmaceutical packaging.
Contract Manufacturing / Third Party Manufacturing
Delwis Healthcare offers comprehensive contract manufacturing and third-party manufacturing services to pharmaceutical buyers seeking to outsource production. Our capabilities include private label manufacturing, where we produce finished dosage forms under a client’s brand name, as well as contract manufacturing for customized formulations. We support clients in meeting global regulatory standards while maintaining flexibility in dosage strengths, packaging formats, and labeling requirements. Our team collaborates closely with buyers to ensure alignment with specific market needs, including regional compliance and labeling specifications. For pharmaceutical manufacturers requiring scalable production, we provide end-to-end solutions, from raw material sourcing to final packaging, ensuring cost-efficiency and adherence to quality benchmarks.
Quality Assurance
Quality assurance at Delwis Healthcare is rooted in rigorous analytical validation and continuous process monitoring. Each batch of Esodel - 40 undergoes comprehensive testing, including high-performance liquid chromatography (HPLC) for active ingredient quantification, dissolution testing to confirm bioavailability, and microbial limit testing to ensure sterility. In-process controls are implemented at critical stages of manufacturing, such as tablet compression and coating, to maintain consistency in product attributes. Batch testing protocols are validated against international pharmacopoeial standards, including USP and EP guidelines, ensuring compliance with regulatory expectations. Additionally, stability studies are conducted to assess shelf-life under accelerated and long-term conditions, providing data for expiration dating and storage recommendations.
Regulatory Compliance
Delwis Healthcare adheres to global regulatory frameworks, including current Good Manufacturing Practices (cGMP), World Health Organization (WHO) guidelines, and ISO 9001 quality management standards. Our manufacturing processes are validated to meet the requirements of regulatory authorities such as the FDA, EMA, and PMDA, ensuring compliance with international pharmacopeial standards. Documentation is maintained in accordance with Good Documentation Practices (GDP), with traceable records for raw materials, production processes, and quality control activities. The facility is regularly audited by third-party inspectors and regulatory bodies to confirm adherence to quality and safety benchmarks. Compliance with environmental regulations and sustainable manufacturing practices further enhances our reputation as a trusted pharmaceutical supplier.
Global Supply Capability
Delwis Healthcare is equipped to deliver bulk supply of Esodel - 40 to international markets through a well-established distribution network. Our export capabilities include seamless logistics partnerships with global freight forwarders and customs brokers, ensuring timely and compliant delivery to destinations across Asia, Africa, Latin America, and Europe. The facility’s production capacity supports large-scale bulk orders, with flexibility to accommodate varying order sizes and packaging requirements. Supply chain reliability is ensured through redundant inventory management systems, real-time tracking, and contingency planning for disruptions. Our commitment to quality and compliance extends to international markets, where we navigate regional regulatory landscapes to provide seamless supply chain solutions for pharmaceutical buyers.
Why Choose Us
Pharmaceutical distributors, exporters, and contract manufacturing partners select Delwis Healthcare for its combination of expertise, compliance, and scalability. Our proven track record in manufacturing proton pump inhibitors like Esodel - 40 positions us as a reliable supplier for bulk supply needs. The facility’s adherence to cGMP, WHO, and ISO standards ensures that every product meets the highest quality benchmarks. Additionally, our global supply chain capabilities and flexible manufacturing solutions enable clients to meet market demands efficiently. With a focus on innovation, sustainability, and customer-centric service, Delwis Healthcare delivers value-driven partnerships that support long-term growth in the pharmaceutical industry.
Bulk Supply Inquiry
Delwis Healthcare offers reliable bulk supply of Esodel - 40 to meet the demands of pharmaceutical manufacturers worldwide. For inquiries regarding bulk orders, packaging customization, or regulatory documentation, contact our sales team at info@delwishealthcare.com.
FAQs
What manufacturing standards does Delwis Healthcare follow for Esodel - 40?
Delwis Healthcare adheres to cGMP, WHO, and ISO standards, ensuring compliance with global regulatory requirements for pharmaceutical manufacturing.
Can Esodel - 40 be produced in different packaging formats?
While Esodel - 40 is currently available in 10x10 Alu Alu packaging, we offer customization options for alternative packaging formats upon request.
What quality control measures are in place for Esodel - 40?
Each batch undergoes HPLC, dissolution testing, and microbial limit testing to ensure consistency and safety.
Is Delwis Healthcare capable of exporting Esodel - 40 to international markets?
Yes, our global distribution network supports exports to Asia, Africa, Latin America, and Europe, with compliance for regional regulatory requirements.
How does Delwis Healthcare ensure scalability for bulk supply?
Our facility is designed for large-scale production, with flexible manufacturing capabilities to meet varying order sizes and market demands.
What is the shelf life of Esodel - 40?
The shelf life of Esodel - 40 is determined through stability studies, with expiration dating based on accelerated and long-term testing protocols.
Can Delwis Healthcare provide documentation for regulatory approvals?
Yes, we provide complete documentation, including batch certificates of analysis, stability data, and regulatory compliance reports.
What is the minimum order quantity for Esodel - 40?
Minimum order quantities are flexible and can be customized based on the buyer’s requirements and production schedules.
How does Delwis Healthcare handle supply chain disruptions?
We implement redundant inventory systems, real-time tracking, and contingency planning to ensure uninterrupted supply chain operations.
Can Delwis Healthcare support private label manufacturing for Esodel - 40?
Yes, we offer private label manufacturing services, allowing clients to produce Esodel - 40 under their brand name while maintaining quality and compliance.
